Evidence map›Paper›PMID 31179279›Full record

ReviewFrontiers in bioengineering and biotechnology2019

Production of 3-Hydroxypropanoic Acid From Glycerol by Metabolically Engineered Bacteria.

Carsten Jers, Aida Kalantari, Abhroop Garg, Ivan Mijakovic

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Engineering 3-Hydroxypropionic Acid Production from Glucose inJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Antimicrobial Compounds in Food Packaging.International journal of molecular sciences · 2023
    Review
  10. EngineeringFrontiers in bioengineering and biotechnology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Engineering Glucose-to-Glycerol Pathway inFrontiers in bioengineering and biotechnology · 2022
    Article
  15. Review
  16. Review
  17. Recent Progress in the Understanding and Engineering of Coenzyme BFrontiers in bioengineering and biotechnology · 2020
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Carsten JersNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Aida KalantariDepartment of Biomedical Engineering, Duke University, Durham, NC, United States.
Abhroop GargNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Ivan MijakovicNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Technical University of Denmark · DKDuke University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3-hydroxypropanoic acid (3-HP) is a valuable platform chemical with a high demand in the global market. 3-HP can be produced from various renewable resources. It is used as a precursor in industrial production of a number of chemicals, such as acrylic acid and its many derivatives. In its polymerized form, 3-HP can be used in bioplastic production. Several microbes naturally possess the biosynthetic pathways for production of 3-HP, and a number of these pathways have been introduced in some widely used cell factories, such as

Indexed as

3-hydroxypropanoic acidbiosynthesiscell factoryglycerolmetabolic engineeringsynthetic biology

Identifiers

PMID31179279
PMCPMC6542942
OpenAlexW2946719419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.